Gene expression data are available at the GEO database, accession \#GSE64263.

Introduction {#sec001}
============

Renewable cell models are widely recognized as valuable platforms for studies of human genotype-phenotype interactions because they are easily manipulated, scalable, and are specific to human physiology (in contrast to lab animal models). Epstein-Barr virus (EBV) transformed lymphoblastoid cell lines (LCLs) are one such commonly-used model. In recent years, LCLs have been used to study genetic influence on disease traits \[[@pgen.1005216.ref001]\], drug response \[[@pgen.1005216.ref002]--[@pgen.1005216.ref005]\], and gene regulation \[[@pgen.1005216.ref006],[@pgen.1005216.ref007]\]. In particular, much of what we now know about associations of human genetic variation with differences in gene regulation is based on studies that used data from LCLs. There is little doubt that many fundamental regulatory principles that we have learned by generating and analyzing data from LCLs are generally shared with primary tissues. However, a critical property of any *in vitro* cellular model is the ability to faithfully recapitulate the specific regulatory properties of the donor's primary tissue. In that regard, though LCLs have clearly been a convenient and useful model, there is concern that factors related to immortalization and cell line maintenance obscure genetic signal in LCLs \[[@pgen.1005216.ref008]--[@pgen.1005216.ref010]\].

A number of studies have characterized differences in gene regulatory phenotypes between LCLs and primary tissues \[[@pgen.1005216.ref011]--[@pgen.1005216.ref015]\]. These have shown that a large number of genes are differentially expressed between primary cells and cell lines, and that thousands of CpG sites are differentially methylated between LCLs and primary blood cells. Our group has also demonstrated disruptions in gene regulation in LCLs by studying multiple independent replicates of LCLs from isolated primary B cells of six individuals and repeatedly subjecting the cell lines to cycles of freeze, thaw, and recovery. We found that newly transformed LCLs (within a few passages after the EBV transformation) largely maintained individual differences in gene expression levels. However, LCLs that had been frozen and thawed at least once (we referred to these as mature LCLs) exhibited a substantial loss of inter-individual variation in gene expression levels \[[@pgen.1005216.ref014],[@pgen.1005216.ref016]\].

On the one hand, it is unlikely that the loss of the donor effect on gene expression would lead to false positive findings of genetic influence on gene regulation. Indeed, we reported that genes associated with previously identified eQTLs retain relatively high variation in gene expression levels between individuals even after repeated freeze-thaw culturing cycles. Yet on the other hand, because much of the individual variation observed in primary tissues is not exhibited by LCLs, studies using the LCL model are limited in their ability to detect donor differences.

The induced pluripotent stem cell (iPSC) system is another renewable cell model that is increasingly used to study individual phenotypic variation because it can ultimately provide access to a wide range of tissue types through the use of differentiation protocols. However, the capacity of iPSCs and derived cell types to faithfully recapitulate *in vivo* physiology is also still largely unknown. Previous studies have noted a significant effect of donor on traits in iPSCs such as hematopoietic \[[@pgen.1005216.ref017]\], neuronal \[[@pgen.1005216.ref018]\] and hepatic \[[@pgen.1005216.ref019]\] differentiation potential. Importantly, the genetic background of iPSCs generated from peripheral blood mononuclear cells and fibroblasts was recently demonstrated to account for more of the variation in gene expression between iPSC lines than any other tested factor such as cell type of origin or reprogramming method \[[@pgen.1005216.ref020]\]. While these findings indicate that reprogramming iPSCs from primary tissues preserves individual variation in gene expression, it is unknown whether reprogramming highly manipulated immortalized cell lines, such as LCLs, to iPSCs can recover the individual gene expression patterns lost during cell line maintenance.

Because LCLs are available in large banks representing disease populations or ethnicities, they are a promising source of starting material for iPSC generation if disruptions in gene regulation do not persist through the reprogramming process. In the present study, we ask whether reprogramming mature LCLs to iPSCs can result in the recovery of individual variation in gene expression that had been lost during the LCL maturation and maintenance process.

Results {#sec002}
=======

To test whether reprogramming LCLs to iPSCs could recover the effect of donor on gene expression profiles, we generated iPSCs from three mature LCLs of each of six Caucasian individuals for a total of 17 pairs of cell lines (one iPSC line failed to reach the requisite ten passages and was excluded from the study; see [methods](#sec010){ref-type="sec"}). We have previously collected gene expression data from the LCLs at earlier stages \[[@pgen.1005216.ref014],[@pgen.1005216.ref016]\]. For the current study, we quantified whole genome gene expression microarray data from the 17 mature LCLs immediately prior to reprogramming and from stable and validated iPSCs. See [Fig 1](#pgen.1005216.g001){ref-type="fig"} for schematic of the study design and [S1 Table](#pgen.1005216.s012){ref-type="supplementary-material"} for the processed gene expression data from all samples.

![Study design.\
Three independent lymphoblastoid cell lines (LCLs) were generated for each of six unrelated Caucasian individuals. LCLs were frozen and thawed seven times. After the seventh thaw, the LCLs were reprogrammed to iPSCs. Gene expression data was collected from LCLs immediately before reprogramming and from stable iPSC lines.](pgen.1005216.g001){#pgen.1005216.g001}

Generation and Validation of the iPSCs {#sec003}
--------------------------------------

We reprogrammed mature LCLs, which had previously undergone seven freeze-thaw culturing cycles, to iPSCs using an episomal transfection approach \[[@pgen.1005216.ref021]--[@pgen.1005216.ref023]\] (see [Methods](#sec010){ref-type="sec"} for more details). We reprogrammed the LCLs in four batches; scheduling LCLs derived from the same individual to different reprograming batches to ensure that no artificial correlation structure was introduced between 'reprograming batch' and 'donor individual' in the process of iPSC generation. All iPSC lines were confirmed to be pluripotent using an embryoid body assay ([Fig 2A](#pgen.1005216.g002){ref-type="fig"} and [S1 Fig](#pgen.1005216.s001){ref-type="supplementary-material"}), qPCR for pluripotency-associated transcription factors ([Fig 2B](#pgen.1005216.g002){ref-type="fig"}), genomic PCR to confirm the absence of reprogramming plasmids ([S2](#pgen.1005216.s002){ref-type="supplementary-material"} and [S3](#pgen.1005216.s003){ref-type="supplementary-material"} Figs), and PluriTest, a bioinformatic classifier designed to assess pluripotency using gene expression data \[[@pgen.1005216.ref024]\] ([S2 Table](#pgen.1005216.s013){ref-type="supplementary-material"}). Three independently established LCLs were successfully reprogrammed into validated iPSCs for all but one individual, for which only two iPSC lines were obtained.

![iPSC generation and validation.\
A. Representative embryoid body staining for iPSC line 5--2 demonstrating differentiation potential for endoderm, mesoderm, and ectoderm lineages. See [S1 Fig](#pgen.1005216.s001){ref-type="supplementary-material"} for results from all lines. Scale bars represent 200 μm B. Results from qPCR for three endogenous pluripotency-related transcription factors, normalized to GAPDH. iPSC 5--1 was randomly chosen as a reference sample.](pgen.1005216.g002){#pgen.1005216.g002}

Recovery of the Individual Signature of Gene Regulation {#sec004}
-------------------------------------------------------

We collected high quality RNA (RIN score range: 7.6--9.9; [S2 Table](#pgen.1005216.s013){ref-type="supplementary-material"}) from LCLs immediately prior to reprogramming and from the stable and validated iPSC lines after at least 10 passages (see [S2 Table](#pgen.1005216.s013){ref-type="supplementary-material"} for specific passage information). We quantified gene expression levels for all samples using the Illumina Human HT12v4 microarray platform. As a first step of our analysis, we excluded data from probes whose target transcripts did not map to a unique Ensembl gene ID, those that spanned an exon-exon junction, and those that were not detected as 'expressed' in at least two samples from either cell type (we note that our general observations are robust with respect to a wide range of this inclusion criteria). We also excluded from the analysis data from probes with a known SNP with a minor allele frequency \> 0.05 in the European population, based on the 1000 Genomes phase I data, to eliminate the possibility of an artificial effect of genotype on the hybridization-based estimates of gene expression levels. We then quantile-normalized the combined data from the remaining probes across all samples. We examined and corrected for array batch using the approach of Johnson et al \[[@pgen.1005216.ref025]\] (see [Methods](#sec010){ref-type="sec"}). Finally, we obtained normalized expression levels for 12,243 genes detected as expressed in our samples ([S1 Table](#pgen.1005216.s012){ref-type="supplementary-material"}). Using a linear model-based Empirical Bayes method (implemented in the *'limma'* R package \[[@pgen.1005216.ref026]\]), we classified 8,185 genes as differentially expressed between iPSCs and LCLs (FDR \< 1%; see [Methods](#sec010){ref-type="sec"} for more details about modeling and hypothesis testing).

Because the regulation of a large percentage of genes was affected by reprogramming (67% of tested genes), we asked whether gene expression patterns specific to the donor individual were recovered in the process. We addressed this question using two approaches. First, we evaluated the overall degree of similarity across cell lines from the same donor by considering summaries of the gene expression phenotypes using clustering analysis and PCA. The rationale for collapsing our gene-specific expression data and considering overall summaries is that complex phenotypes can often be the result of a large combination of genotype contributions and we are interested to learn whether the overall data from cell lines exhibits a clear signature of the donor. In our second approach, we focused on gene specific patterns by partitioning the variance in expression levels for individual genes and testing for differences between the entire distributions of gene expression levels across cell lines. In this approach we are considering expression patterns of individual genes as independent data points. The rationale for the gene-specific approach is that studies of the genetic basis for regulatory variation (such as eQTL mapping studies) nearly always consider the expression phenotypes of individual genes and we are interested to learn the extent to which the effect of donor genotype on gene expression levels can be studied using a given cell model.

To evaluate overall clustering properties in the expression data from the two cell types, we performed hierarchical clustering analysis and PCA. As we performed these analyses, we consistently observed that data from the second iPSC line of individual 4 (line marked as 4--2 in our figures) accounts for a disproportionate amount of variance ([S4B Fig](#pgen.1005216.s004){ref-type="supplementary-material"}). This individual is a clear outlier and its iPSC is associated with the lowest PluriScore in our study ([S2 Table](#pgen.1005216.s013){ref-type="supplementary-material"}). We have excluded the data from this individual from subsequent analyses. Importantly, we have confirmed (as we show in supplementary figures), that our conclusions our robust with respect to this decision.

Using data from all 12,243 genes detected as expressed, mature LCLs fail to consistently cluster by the individual from whom they were initially derived, in accordance with our previous observations ([Fig 3A](#pgen.1005216.g003){ref-type="fig"}, [S4A](#pgen.1005216.s004){ref-type="supplementary-material"} and [S5A](#pgen.1005216.s005){ref-type="supplementary-material"} Figs). Data from the corresponding iPSC lines, however, cluster by the individual of origin, indicating a large degree of recovery of donor gene expression patterns ([Fig 3B](#pgen.1005216.g003){ref-type="fig"}, [S4B](#pgen.1005216.s004){ref-type="supplementary-material"} and [S5B](#pgen.1005216.s005){ref-type="supplementary-material"} Figs). Another method to assess overall clustering properties is through the use of principal components analysis. Taking this approach, we found that clustering of the expression data by individual of origin is substantially more pronounced in the iPSCs than in the LCLs ([Fig 3](#pgen.1005216.g003){ref-type="fig"} and [S4 Fig](#pgen.1005216.s004){ref-type="supplementary-material"}). Indeed, the average pairwise Euclidean distances of expression data projections on the first two PCs are significantly smaller within cell lines derived from the same individual than those from different individuals for iPSCs (*P* \< 10^-15^), but not for LCLs (*P* = 0.13; [S3 Table](#pgen.1005216.s014){ref-type="supplementary-material"}).

![Improved clustering properties after reprogramming to iPSCs.\
A. Results from hierarchical clustering analysis of microarray gene expression and expression data projections on principal components axes 1 and 2 from cycle 7 LCLs and B. iPSCs.](pgen.1005216.g003){#pgen.1005216.g003}

To estimate the magnitude of the donor effect on gene expression patterns in LCLs and iPSCs, we compared the pairwise correlations of expression data from cell lines derived from the same donor to pairwise correlations of data from cell lines derived from different individuals ([S6 Fig](#pgen.1005216.s006){ref-type="supplementary-material"}). On average, both within- and between-donor correlation coefficients are significantly higher in iPSCs than in the LCLs they were initially derived from (p \< 10^-4^ and p \< 10^-8^ for within- and between-donor correlations, respectively). In other words, regardless of the individual of origin, we observed less variation in gene expression between iPSCs than LCLs. Yet, though iPSCs harbor less variation overall, the proportion of variation in gene expression that is explained by donor is significantly higher in the iPSCs compared with the LCLs (*P* \< 10^-15^). Indeed, using a single factor ANOVA, we estimate that donor explains, on average, 24.5% of the variance in gene expression in iPSCs but only 6.9% in LCLs.

In addition to within-donor correlations, we were specifically interested in identifying genes that were highly variable across donors. We thus proceeded by considering the ratio of between- to within-individual variation in gene expression levels in the two cell types. On average, we found a significantly higher ratio of between-to-within individual variance in gene expression levels in iPSCs compared with data from the LCLs (*P* \< 10^-15^; recall that in this analysis we consider expression patterns of individual genes as independent data points), despite significantly higher overall variance in LCL gene expression (*P* \< 10^-14^; [Fig 4](#pgen.1005216.g004){ref-type="fig"}, and [S7](#pgen.1005216.s007){ref-type="supplementary-material"} and [S8](#pgen.1005216.s008){ref-type="supplementary-material"} Figs). We identified 1,620 genes whose expression levels were significantly associated with donor in iPSCs (single factor ANOVA FDR \< 0.05; see [S9 Fig](#pgen.1005216.s009){ref-type="supplementary-material"} for histogram of p-values) but only 77 such genes in LCLs.

![Comparison of ability to detect inter-individual gene expression variation.\
A. Density plot of between donor variance to within donor variance in gene expression for all expressed genes in iPSCs and LCLs. The dotted line indicates the threshold ratio corresponding with significant association between gene expression and donor. X-axis was truncated at 8.0; 0.8% of the data are not plotted here for visualization purposes. B. Density plot of total variance in LCLs and iPSCs. X-axis was truncated at 0.1; 3.7% of the data are not plotted here. See [S7 Fig](#pgen.1005216.s007){ref-type="supplementary-material"} for plots including all the data.](pgen.1005216.g004){#pgen.1005216.g004}

Functional Relevance of Highly Variable Genes {#sec005}
---------------------------------------------

We tested for enrichment of functional annotation related to tissue-expression, disease involvement, and biological process (using the online database Lynx \[[@pgen.1005216.ref027]\]) among genes whose expression levels are significantly associated with donor. While these results do not shed much light on the functional importance of these gene sets, we note that genes exhibiting high individual variation in iPSCs are enriched in genes expressed in embryonic tissue while those in LCLs are not significantly enriched in any functional category we tested. The complete set of results for tissue, disease, and biological process enrichment is available in [S4](#pgen.1005216.s015){ref-type="supplementary-material"} and [S5](#pgen.1005216.s016){ref-type="supplementary-material"} Tables.

Finally, we considered the relevance of our findings with respect to previously published eQTL studies in LCLs. Our sample of 6 individuals is too small to allow identification of eQTLs. As an alternative, we compared individual variation in expression levels between genes previously associated with an eQTL in LCLs \[[@pgen.1005216.ref006]\], and genes for which an eQTL was not identified. To do so, we randomly selected data from one biological replicate (one LCL and its corresponding iPSC) from each individual.

In both LCLs and iPSCs, the average coefficients of expression variation were significantly higher in genes previously associated with eQTLs than in genes for which eQTLs were not identified (*P* \< 10^-10^ and *P* = 0.009, for LCLs and iPSCs, respectively; [Fig 5](#pgen.1005216.g005){ref-type="fig"} and [S10 Fig](#pgen.1005216.s010){ref-type="supplementary-material"}). As expected (given that these eQTLs were originally observed in LCLs, and that LCLs have greater overall variation), the coefficients of variation are significantly higher in eQTL-associated genes in LCLs than iPSCs (*P* \< 10^-9^).

![Genes with eQTLs are highly variable in both cell types.\
Boxplot of coefficients of variation of gene expression in genes with and without eQTLs previously identified in LCLs \[[@pgen.1005216.ref006]\], plotted for LCLs and iPSCs.](pgen.1005216.g005){#pgen.1005216.g005}

Discussion {#sec006}
==========

The utility of renewable cell lines for population genetics studies and as models of complex disease depends on the preservation of the genotype-phenotype relationship in the cell line. Thus, the most useful cell line models would retain a strong influence of individual of origin on their phenotypes, including molecular properties such as gene regulatory patterns. In previous work, we reported that freeze-thaw cycling of LCLs, a standard and required practice in long-term cell line maintenance, reduces the effect of donor on the cell line's gene expression profile \[[@pgen.1005216.ref016]\]. In fact, we have found that whole-genome gene expression profiles from LCLs that were generated from different individuals are typically as similar to each other as data from independently established replicates of LCLs from the same individual. We suggested that LCLs that have experienced one or more freeze-thaw cycles may be clonally selected for, resulting in a convergent "LCL regulatory phenotype", which has an advantage growing in culture but masks many of the original gene expression differences between the donor individuals.

Apart from the concern regarding the loss of much of the gene regulatory variation between donors, an intrinsic limitation of the LCL model system is that it theoretically represents the biology of only one primary cell type, B cells. As might be expected, all existing collections of renewable cell lines from human population samples include only easily accessible primary tissues such as blood cells, adipocytes, and skin fibroblasts. Many cell types affected by disease, for example cardiomyocytes, hepatocytes, and neurons, cannot be directly studied using existing human cell line panels. In order to study variation in the most relevant phenotypes and disease processes, we need access to population samples that model additional cellular contexts.

The advent of iPSC technology may have provided the answer. It is now possible to establish renewable iPSC lines from population samples and differentiate them to multiple different cell types for which large collections are currently unavailable. One can establish iPSCs from newly collected fibroblasts or fresh blood samples, but a most attractive possibility is to generate iPSC panels from the already available extensive collections of human LCLs. We thus asked whether individual variation in gene expression levels can be restored by reprograming LCLs into iPSC lines.

Recovery of Individual Variation {#sec007}
--------------------------------

We have shown that not only does the iPSC model exhibit a strong effect of donor on overall gene expression, but in fact the process of reprogramming highly manipulated immortalized cell lines to iPSCs recovers the inter-individual variation in gene expression lost during long term cell line maintenance.

The stronger clustering properties of expression data from iPSCs compared to LCLs suggest that iPSCs are better able to capture donor differences in gene regulation than LCLs. We could detect no significant difference between Euclidean distances within- and across- individuals in the projections of gene expression data from LCLs on the first two principal components of variation, indicating that donor is not a significant global source of gene expression variation in the LCL model. This observation is consistent with our previous findings \[[@pgen.1005216.ref016]\]. In contrast, we observed a dramatic increase in the number of genes whose expression was significantly associated with donor in iPSCs, and a higher average variance in expression explained by individual of origin in the iPSCs compared with LCLs. These findings indicate that iPSCs reprogrammed from LCLs are a suitable model for studies of donor differences in gene regulation and genotype-phenotype interactions.

Our work does not provide direct evidence for a mechanism by which iPSCs regain the effect of donor on gene expression. Previously \[[@pgen.1005216.ref016]\] we have hypothesized that the loss of individual variation in gene expression levels in LCLs is due to selection in culture for the fastest growing LCLs. We suggested that this selection results in a convergence to a gene regulatory profile that is common for all mature LCL cultures. In a recent study \[[@pgen.1005216.ref028]\] we have found that DNA methylation profiles in iPSCs reprogrammed from different somatic cell types of the same individuals are practically identical, while we observed hundred of thousands of methylation differences between the precursor somatic cells. Global reprograming of the epigenetic landscape in iPSC lines could potentially be the reason that the LCL gene regulatory signature has been largely replaced by a new regulatory program, which no longer reflects the selection pressures relevant to LCL culturing.

We note that despite their diminished ability to reflect donor differences, attempts to identify instances of genetic regulation of LCL gene expression in mature cell lines have been considered largely successful. Indeed, here we report that genes previously identified as associated with an eQTL in LCLs exhibit higher variance in mature LCLs than those without one. However, our observations suggest that, for future eQTL mapping studies, iPSCs may be a better system than LCLs. While 28.6% of genes with a significant donor effect in LCLs are associated with a previously identified eQTL in LCLs, only 5.9% of genes with a significant donor effect in iPSCs are associated with such an eQTL. Although expressed in LCLs, often at appreciable levels ([S11 Fig](#pgen.1005216.s011){ref-type="supplementary-material"}), the majority (\>95%) of genes with a strong donor effect in iPSCs do not show such an effect in LCLs. Put together, these observations support our assertion that iPSC can be a better model than LCLs for detecting eQTLs, and more generally, for studies of inter-individual differences in gene regulation.

Technical Noise Associated with Reprogramming {#sec008}
---------------------------------------------

In any cell model, it is important to consider the magnitude of noise introduced by cell culture relative to biological signal. We note a substantial decrease in within-individual expression correlations for a cell line with a low PluriScore, indicating that we should perhaps reconsider acceptable scores for studies of individual phenotypic variation. However, other technical considerations do not seem to have a marked effect on overall clustering properties. For example, data from the single iPSC line that retained EBV (individual 3, replicate 2; [S3 Fig](#pgen.1005216.s003){ref-type="supplementary-material"}) clustered with the other iPSC lines derived from that individual. Additionally, we reprogrammed iPSCs in four groups and collected expression data at varying passages (between passage 11 and 13, [S2 Table](#pgen.1005216.s013){ref-type="supplementary-material"}) without apparent batch effects. Because it is currently unclear which factors significantly affect our ability to detect donor differences, potential sources of noise need to be more systematically studied and appropriately controlled for.

Much of the excitement surrounding iPSCs is based on their ability to differentiate into terminal cell types, providing a renewable substitute for previously inaccessible tissues. Our study does not provide direct evidence that iPSC-derived differentiated cells will also reflect donor differences, however because the pluripotent state is relatively well-conserved compared to terminal cell types \[[@pgen.1005216.ref029],[@pgen.1005216.ref030]\], we expect that tissues derived from iPSCs will demonstrate an even stronger donor effect on gene expression. That said, we suggest that this expectation needs to be independently confirmed in each differentiated cell type before they are carried into further studies.

Conclusion {#sec009}
----------

Because LCLs are available in large banks that represent panels of ethnic groups and disease populations, they are a popular cell model for genetic research and have been extensively studied. Recent advances in iPSC reprogramming protocols \[[@pgen.1005216.ref022],[@pgen.1005216.ref023]\] have also positioned LCLs as a promising source of starting material for iPSC generation. Here, we have presented the recovery of donor gene expression patterns through the process of reprogramming highly manipulated LCLs to iPSCs, both validating the choice of iPSCs to study donor differences in physiology and the use of LCLs as an appropriate starting material for iPSC generation.

Materials and Methods {#sec010}
=====================

Ethics Statement {#sec011}
----------------

In this study, blood samples from Research Blood Components were analyzed anonymously. Research Blood Components obtained IRB approval and written informed consent from each donor, giving permission to collect their blood and use or sell it at Research Blood Components\'s discretion, for research purposes.

Sample Acquisition {#sec012}
------------------

Whole blood was collected from six healthy Caucasian donors by Research Blood Components LLC (Brighton, MA) with IRB consent between 2009 and 2010. B-Cell isolation and LCL generation were performed at the University of Chicago as described previously \[[@pgen.1005216.ref014]\]. Between February 2011 and October 2012, each line was thawed, cultured, and re-frozen every three months, for a total of six freeze-thaw cycles prior to use in our study \[[@pgen.1005216.ref016]\]. LCLs were cultured in RPMI with 20% FBS and frozen in Recovery Cell Culture Freezing Media (Life Technologies).

iPSC Generation and Validation {#sec013}
------------------------------

All cell culture was performed at 37°C, 5% CO~2~, and atmospheric O~2~. From each individual, three biological replicates of LCLs were reprogrammed to iPSCs using a similar method to that described previously \[[@pgen.1005216.ref022],[@pgen.1005216.ref023]\]. LCLs were transfected in four batches between August 2013 and January 2014 ([S2 Table](#pgen.1005216.s013){ref-type="supplementary-material"}). One million cells were transfected with 2 μg of each episomal plasmid encoding *OCT3/4*, *shP53*, *Lin28*, *SOX2*, *L-MYC*, *KLF4*, and GFP(Addgene plasmids 27077, 27078, 27080, 27082 \[[@pgen.1005216.ref021]\]) using the Amaxa transfection program X-005. For more details see: <http://giladlab.uchicago.edu/data/LCL_Reprogramming.pdf>. Transfected cells were grown in suspension for a week in hESC media (DMEM/F12 supplemented with 20% KOSR, 0.1mM NEAA, 2mM GlutaMAX, 1% Pen/Strep, 0.1 mM BME, and 12.5 ng/mL human bFGF) supplemented with 0.5mM sodium butyrate between days 2--12 post-nucleofection. After seven days, cells were plated on gelatin-coated plates with CF-1 irradiated mouse embryonic fibroblasts and manually passaged as colonies for at least 10 passages. After day 12, cells were grown in hESC media without sodium butyrate. Media was changed every 48 hours. Cell pellets were collected and stored at -80° C until extraction. One biological replicate from individual five failed to reach passage ten and was excluded from all analyses.

Embryoid body assays were performed following the protocol used by Romero et al \[[@pgen.1005216.ref031]\]. Briefly, embryoid bodies were generated by manual colony detachment and were grown in suspension for seven days on low adherent plates in bFGF-free hESC media. They were then plated on 12 well gelatin-coated plates and grown for another seven days in DMEM-based media. Cells were fixed and stained using antibodies against nestin (1:250 SC-71665, Santa Cruz Biotech), α-smooth muscle actin (1:1500, CBL171, Millipore), alpha-Fetoprotein (1:100, SC-130302, Santa Cruz Biotech), and HNF3β (1:100 SC-6554, Santa Cruz Biotech) to detect ectoderm, mesoderm, and endoderm lineages respectively.

DNA was extracted using ZR-Duet DNA/RNA MiniPrep (Zymo) kits according to the manufacturer's instructions. To assess for the presence of plasmid or EBV genome in iPSCs, PCR was performed using the genomic DNA collected from the iPSCs as template (collected at the same time as expression measurements) with primers designed to amplify the 3' end of the EBNA-1 gene (present in both the EBV genome and all reprogramming plasmids) and NEBNext High-Fidelity 2X PCR Master Mix. For the sample with detectable EBNA-1, we also performed genomic PCR using primers to amplify a region common to all PXCLE reprogramming plasmids, and primers that amplify the BBRF1/LMP2 gene found only in the EBV genome to determine the source of foreign DNA. Primer sequences are available in [S6 Table](#pgen.1005216.s017){ref-type="supplementary-material"}. Fibroblast DNA containing reprogramming plasmids at 0.02 pg/μL was used as a positive control for the PXCLE and EBNA-1 primer sets. LCL DNA (from YRI lines 18508 and 19238) were used as positive controls for the EBV and EBNA-1 primer sets. Fibroblast DNA was used as a negative control for all primer sets.

RNA was extracted using ZR-Duet DNA/RNA MiniPrep kits according to the manufacturer's instructions with the addition of a DNAse treatment step prior to RNA extraction. cDNA was then synthesized using Maxima First Strand cDNA Synthesis Kit (Thermo-Scientific.) RT-PCR for endogenous transcripts of three pluripotency-related transcription factors was performed for all iPSC lines using SYBR Select master mix (Life Technologies.) Primers sequences are available in [S6 Table](#pgen.1005216.s017){ref-type="supplementary-material"}. Data were analyzed using Viia7 software (Life Technologies). All expression levels were normalized to GAPDH. Expression was measured relative to a randomly selected iPSC line.

Gene Expression Quantification {#sec014}
------------------------------

Cell pellets were obtained from LCLs immediately before transfection and from stable iPSCs after at least ten passages. RNA concentration and quality was estimated using the Agilent 2100 Bioanalyzer. Donor expression profiles were quantified using Illumina HumanHT-12 v4 Expression BeadChip Microarrays by the Functional Genomics Core at University of Chicago. Samples were hybridized across three array batches. Biological replicates from an individual were assigned to different batches to exclude a relationship between batch and individual. The array data were also used for the PluriTest assay as described previously \[[@pgen.1005216.ref024]\].

Data Processing and Analysis {#sec015}
----------------------------

Raw probe data were filtered for probes whose target transcripts were detected as expressed (*P* \< 0.05) in at least two samples. Probes targeting expressed transcripts were then mapped to the hg19 reference genome. We excluded those with a quality score below 37, those that did not map uniquely to an Ensembl gene ID, that spanned an exon-exon junction, or that contained a SNP with MAF \< 0.05 in European populations (calculated using 1000 Genomes phase I integrated call sets). After filtering, probe intensities from all samples were background corrected, quantile-normalized, and log-2-transformed using the R package *'lumi'* \[[@pgen.1005216.ref032]\]. For genes represented by multiple probes, only the 3' most probe was included in subsequent analyses to represent the most complete transcript. Finally, array batch was corrected for using an empirical Bayes method implemented in the R package *'sva'*\[[@pgen.1005216.ref025],[@pgen.1005216.ref033]\] This data is available in [S1 Table](#pgen.1005216.s012){ref-type="supplementary-material"}.

Differential expression was estimated using a linear model based empirical bayes method implemented in the R package *'limma* \[[@pgen.1005216.ref026]\]*'*. Dendrograms were generated for matrices of pairwise Pearson product-moment correlation coefficients. For principal component analysis, expression data was mean-centered by gene across all individuals. The outlier individual 4--2 was omitted prior to hierarchical clustering analysis and PCA. All analyses, figures, and tables presented in the supplement include data from all individuals. Proportion of variance due to donor was estimated as the adjusted R^2^ value from a linear model including a term for each individual. Genes with FDR-adjusted p-values \< 0.05 from a one-way ANOVA across individuals were classified as significantly associated with donor. eQTL data were downloaded from the Pritchard group eQTL browser: <http://eqtl.uchicago.edu>. Functional group enrichment was assessed using the web-based gene annotation database Lynx: <http://lynx.ci.uchicago.edu> using all expressed genes subjected to our filtering criteria as background.

Accession Numbers {#sec016}
-----------------

Gene expression data are available at the GEO database, accession \#GSE64263.

Supporting Information {#sec017}
======================

###### Embryoid body assay.

Immunocytochemistry approach to test for a cell line's ability to spontaneously differentiate through endoderm: HNF3β and α-fetoprotein (AFP), mesoderm: smooth muscle actin (SMA), and ectoderm: nestin lineages. Scale bar: 200 μm. Individual channel levels, brightness, and contrast were adjusted using Adobe Photoshop CS6.

(TIF)

###### 

Click here for additional data file.

###### PCR for EBNA-1.

Reprogramming vectors and Epstein-Barr virus are absent in all iPSC lines except 3--2 (see [S3 Fig](#pgen.1005216.s003){ref-type="supplementary-material"})**1**.4--1 iPSC, **2.** 6--3 iPSC, **3.** 5--2 iPSC, **4.** 3--3 iPSC, **5.** 3--2 iPSC, **6.** 6--2 iPSC, **7.** 2--3 iPSC, **8.** 5--1 iPSC, **9.** 1--2 iPSC, **10.** 1--1 iPSC, **11.** 3--1 iPSC, **12.** 3--3 iPSC, **13.** 2--2 iPSC, **14.** 2--1 iPSC, **15.** 4--2 iPSC, **16.** 1--3 iPSC, **17.** 6--1 iPSC, **18.** Reprogramming plasmids (positive control) **19.** LCL DNA (YRI lines 18508 and 19238, positive control). **20.** Fibroblast DNA (negative control), **21.** Water.

(TIF)

###### 

Click here for additional data file.

###### PCR for PCXLE (plasmid) and EBV genome for iPSC line 3--2.

iPSC 3--2 exhibits presence of EBV and absence of reprogramming plasmids.**1**.3--2 iPSC/EBNA-1 primer set, **2.** 3--2 iPSC/PXCLE primer set, **3.** 3--2 iPSC/EBV primer set, **4.** Reprogramming plasmid template/EBNA-1 primer set, **5.**Reprogramming plasmid template/PXCLE primer set, **6.** Reprogramming plasmid template/EBV primer set, **7.** LCL DNA/EBNA-1 primer set, **8.** LCL DNA/PCXLE primer set, **9.** LCL DNA/EBV primer set. **10.** Fibroblast DNA/EBNA-1 primer set **11.** Fibroblast DNA/PCXLE primer set **12.** Fibroblast DNA/EBV primer set.

(TIF)

###### 

Click here for additional data file.

###### Clustering Analysis.

A. Results from hierarchical clustering analysis of microarray gene expression and expression data projections on principal components axes 1 and 2 from cycle 7 LCLs and B. iPSCs. Includes data from all lines.

(TIF)

###### 

Click here for additional data file.

###### Correlation Heatmaps.

Heatmap generated from pairwise correlation matrix (pearson product-moment correlation coefficients) for A. LCLs and B. iPSCs. Includes data from all lines.

(TIF)

###### 

Click here for additional data file.

###### Within and between individual expression correlation.

Pairwise Pearson correlation coefficients for gene expression data from lines derived from the same individual and across different individuals for both cell types. iPSCs demonstrate increased correlation both within and across individuals compared with LCLs. Includes data from all lines.

(TIFF)

###### 

Click here for additional data file.

###### Density plots of gene expression variance.

A. Density plot of between donor variance to within donor variance in gene expression for all expressed genes in iPSCs and LCLs The dotted line indicates the threshold corresponding with significant association between gene expression and individual of origin. All data are plotted; calculations exclude the outlier. B. Density plot of total variance in LCLs and iPSCs. All data are plotted; calculations exclude the outlier.

(TIF)

###### 

Click here for additional data file.

###### Density plots of gene expression variance in all lines.

A. Density plot of between donor variance to within donor variance in gene expression for all expressed genes in iPSCs and LCLs. The dotted line indicates the threshold corresponding with significant association between gene expression and individual of origin. X-axis was truncated at 8.0; 0.67% of the data are not plotted here for visualization purposes. Calculations include data from all lines. B. Density plot of total variance in LCLs and iPSCs. X-axis was truncated at 0.1; 4.0% of the data are not plotted here. Calculations include data from all lines. C. Density plot of between donor variance to within donor variance in gene expression for all expressed genes in iPSCs and LCLs. The dotted line indicates the threshold corresponding with significant association between gene expression and individual of origin. Calculations include data from all lines and all data are plotted. D. Density plot of total variance in LCLs and iPSCs. Calculations include data from all lines and all data are plotted.

(TIF)

###### 

Click here for additional data file.

###### Unadjusted p-values for donor effect.

Histogram of unadjusted p-values from ANOVA F-test across the factor individual of origin for A. iPSCs and B. LCLs. Includes data from all lines.

(TIF)

###### 

Click here for additional data file.

###### Coefficient of variation in genes with and without eQTLs.

Boxplot of coefficients of variation of gene expression in genes with and without eQTLs previously identified in LCLs plotted for LCLs (*P* \< 10^-10^) and iPSCs (*P* = 0.01). Includes data from all lines.

(TIFF)

###### 

Click here for additional data file.

###### Expression in genes with a donor effect in iPSCs.

Mean gene expression levels for genes for which a donor effect was detected in iPSCs compared to all genes. Genes with a strong iPSC donor effect are expressed in LCLs, in fact with a higher mean expression value than the genome-wide average (*P* \< 10^-15^). These genes exhibit significantly higher expression than the genome-wide average in iPSCs as well (*P* \< 10^-15^).

(TIFF)

###### 

Click here for additional data file.

###### Expression data and analysis results for all 15,306 expressed genes.

Columns 1:34: processed expression levels (see [methods](#sec010){ref-type="sec"}) for each sample, 35: p-value from test for differential expression between LCLs and iPSCs (limma) 36: FDR-adjusted p-value for differential expression between LCLs and iPSCs (limma). 37: FDR- adjusted F-test p-values from test for donor effect in iPSCs. 38: FDR- adjusted F-test p-values from test for donor effect in LCLs.

(TXT)

###### 

Click here for additional data file.

###### Sample information.

Includes the following information for all lines: sample ID, gender, reprogramming, extraction, and array batch assignments and dates, RIN scores, passage of RNA collection for iPSCs, and PluriTest scores for all samples.

(XLSX)

###### 

Click here for additional data file.

###### Euclidean distances between clusters in principal components analysis.

Euclidean distances of sample projections on the first two principle component axes within and between individuals averaged over all samples for each cell type, demonstrating significantly lower within-individual distances compared to between-individual distances in iPSCs but not LCLs, regardless of outlier inclusion status.

(XLSX)

###### 

Click here for additional data file.

###### Lynx enrichment analysis in LCLs.

Enrichment results from selected GO categories for genes with a significant donor effect in LCLs. Data downloaded from the online database Lynx.

(XLSX)

###### 

Click here for additional data file.

###### Lynx enrichment analysis in iPSCs.

Enrichment results from selected GO categories for genes with a significant donor effect in iPSCs. Data downloaded from the online database Lynx.

(XLSX)

###### 

Click here for additional data file.

###### PCR primer information.

Sequence, use, and source of primers used for PCR and qPCR.

(XLSX)

###### 

Click here for additional data file.

We thank Minal Çalişkan for providing the LCLs used in the study and all members of the Gilad lab for helpful discussion about data analysis and study design, with special thanks to Nicholas Banovich, John Blischak, Sidney Wang, and Irene Gallego Romero.

[^1]: I have read the journal\'s policy and the authors of this manuscript have the following competing interests: JKP is on the advisory board of 23andme with stock options.

[^2]: Conceived and designed the experiments: YG JKP SMT. Performed the experiments: SMT BJP JB KP. Analyzed the data: SMT CK. Contributed reagents/materials/analysis tools: YG JKP. Wrote the paper: SMT YG JKP BJP CK KP JB.
